Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
. Lazareva (Moscow, Russian Federation), N. Alyabyeva (Moscow, Russian Federation), E. Brzhozovskaya (Moscow, Russian Federation), O. Shamina (Moscow, Russian Federation). Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow. 1166

Member's Comments

No comment yet.

Related content which might interest you: Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 The dynamics of antibiotic resistance of nasopharyngeal pneumococcus isolates in children in Moscow for 2010-2018 Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden Source: Eur Respir J 2016; 47: 1208-1218 Year: 2016 Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine Source: Eur Respir J 2013; 42: 1595-1603 Year: 2013 Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma Year: 2013 Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population Source: Eur Respir J 2016; 48: 1492-1496 Year: 2016 Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Role of pneumococcal vaccine on the incidence of childhood empyema Source: Breathe 2010; 6: 366-367 Year: 2010 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 The development of pneumococcal infection in military populations Source: Eur Respir J 2004; 24: Suppl. 48, 364s Year: 2004 Indication of pneumococcal vaccination in CF patients Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly Source: Eur Respir J 2010; 36: 608-614 Year: 2010